Current Opinion in Cardiology was launched in 1985. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
William J. McKenna
Dr William McKenna is Professor of Cardiology, at University College London, UK and Clinical Director of The Heart Hospital, University College London Hospitals Trust. He was born in Montreal, Canada and completed a Bachelor of Arts Degree at Yale University before graduating from McGill University Medical School. He completed Internal Medicine Training in at the Royal Victoria Hospital in Montreal and in 1976 moved to the Hammersmith Hospital Royal Postgraduate Medical School in London to train in cardiology. In 1988 he took up a post as Sugden Senior Lecturer in the Division of Cardiological Sciences at St George's Hospital Medical School and in 1993 was made professor of cardiac medicine. In October 2000 he was appointed British Heart Foundation (BHF) Professor of Molecular Cardiology and in July 2003 moved to University College London (UCL) as Professor of Cardiology and was appointed Clinical Director of The Heart Hospital, University College London Hospital (UCLH) NHS Trust from September 2004. In August 2008 he was appointed Acting Director (West) of the Institute of Cardiovascular Science, UCL/UCLH Trust. His main interests have been in clinical and basic research of the cardiomyopathies. His recent work has contributed to the identification of disease-causing genes in hypertrophic, dilated and arrhythmogenic right ventricular cardiomyopathy, to the establishment of new diagnostic criteria within the context of familial disease, and to the establishment of algorithms to identify patients at high risk of sudden death.
William T. Abraham
William T. Abraham, M.D., F.A.C.P., F.A.C.C. is Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at The Ohio State University College of Medicine, USA. He also serves as Deputy Director of the Dorothy M. Davis Heart and Lung Research Institute. Dr Abraham earned his medical degree from Harvard Medical School in Boston, Massachusetts, following which he completed his residency in internal medicine and fellowships in cardiology and heart failure/cardiac transplantation at the University of Colorado Health Sciences Center. He previously held faculty appointments at the University of Colorado, the University of Cincinnati, and the University of Kentucky. He is board certified in Internal Medicine and in Cardiovascular Diseases. Dr Abraham's research interests include the role of the kidney in heart failure, neurohormonal mechanisms in heart failure, sleep disordered breathing in heart failure, and clinical drug and device trials in heart failure and cardiac transplantation. Dr Abraham has received grants from the National Institutes of Health, the American College of Cardiology, and the Aetna Quality Care Foundation and has participated as Principal Investigator in more than 100 multicenter clinical drug and device trials. In addition to authoring more than 600 original papers, abstracts, book chapters, and review articles, Dr Abraham has co-edited a leading textbook on heart failure entitled Heart Failure: A Practical Approach to Treatment. Dr Abraham serves on the editorial boards of several major journals including Congestive Heart Failure and Journal Watch Cardiology. He is also a scientific reviewer for such publications as Circulation, the European Heart Journal, and the Journal of the American College of Cardiology. Dr Abraham has been recognized as one of the “Best Doctors in America” for six consecutive years.
Dr Feldman MD, PhD, FACC, FAHA is the Director of Heart Failure and Cardiac Transplant at The Ohio State University (OSU), USA. Dr Feldman is also the director of the heart failure fellowship program at OSU. He has appointments in the Departments of Cardiovascular Medicine, Physiology and Cell Biology as well as in the school of Pharmacy.
Dr Feldman's research interests include the study of G-protein coupled receptors, mechanisms of heart failure, genomic-mediated developmental changes and cardiac transplantation. He is currently funded by multiple National Institute of Health grants and the Heart failure Society of America. His research endeavors have included both basic and clinical research as he has extensive publications in both clinical and basic science. Despite his research, Dr Feldman continues to have a busy clinical practice. His clinical focus is cardiac transplant, end-stage disease management, and critical care.